ESR1 and breast neoplasm: Preclinical studies using 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivatives and 99mTc-glutamate peptide estradiol (GAP-EDL) were reported for functional SPECT imaging of ER-positive breast tumors [28, 29].